More Research Needed To Determine Whether J&J Vaccine Causes Rare Blood Clots


Share on whatsapp
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on email
Share on print

The Johnson & Johnson Covid-19 vaccine will take a pause from South Africa’s inoculation rollout plans. Health Minister Zweli Mkhize made the announcement of the temporary suspension of the vaccine after US health authorities called for a pause to the administering of the vaccine at home. It was in the wake of six recipients in America developing a rare disorder involving blood clots. The recipients were all women between the ages of 18 and 48. In South Africa, almost 290 000 healthcare workers have received the J&J vaccine.

Guest: Ministerial Advisory Committee(MAC) Member on Covid-19, Professor Ian Sanne

More Posts for Show: NRA

News Headlines

May 18, 2022
Fajr Athaan


58:00 Minutes
Prayer Begins Athaan
Fajr06:07 06:10
Thuhr12:43 12:46
Asr15:32 15:35
Maghrib17:51 17:54
Isha19:13 19:16
Open chat